What Is 3-phosphoserine aminotransferase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 3-Phosphoserine aminotransferase (PSAT1) is an enzyme encoded by the PSAT1 gene in humans, catalyzing the conversion of 3-phosphoserine to phosphohydroxypyruvate in serine biosynthesis. It plays a key role in the phosphorylated pathway of L-serine production, essential for cellular metabolism and neurological function.

Key Facts

3-Phosphoserine aminotransferase is encoded by the PSAT1 gene located on chromosome 17q25.3
The enzyme catalyzes the second step in the phosphorylated serine biosynthesis pathway
It converts 3-phosphoserine to phosphohydroxypyruvate using glutamate as an amino donor
Mutations in PSAT1 are linked to neurodevelopmental disorders and brain malformations
The enzyme has a molecular weight of approximately 42 kDa and functions as a dimer

Overview

3-Phosphoserine aminotransferase, also known as phosphoserine aminotransferase 1 (PSAT1), is a critical enzyme in the biosynthesis of the amino acid L-serine. This metabolic pathway occurs primarily in the liver and brain, where serine is required for protein, phospholipid, and neurotransmitter synthesis.

The enzyme functions in the cytosol and is part of the three-step pathway that converts 3-phosphoglycerate to serine. Its activity is tightly regulated due to serine’s role in one-carbon metabolism and nucleotide synthesis.

Gene location: The PSAT1 gene is located on the long arm of chromosome 17 at position q25.3, a region associated with several metabolic and neurological conditions.
Enzyme class: It belongs to the aminotransferase family, specifically the aspartate aminotransferase subfamily, which uses pyridoxal 5'-phosphate (PLP) as a cofactor.
Reaction catalyzed: PSAT1 converts 3-phosphoserine and 2-oxoglutarate into phosphohydroxypyruvate and glutamate in a reversible transamination reaction.
Tissue expression: Highest expression levels are found in the liver, brain, and pancreas, with lower activity in muscle and kidney tissues.
Evolutionary conservation: The enzyme is highly conserved across mammals, with human and mouse PSAT1 sharing over 95% amino acid sequence identity.

How It Works

The enzymatic mechanism of 3-phosphoserine aminotransferase involves a classic PLP-dependent transamination process, where the amino group from 3-phosphoserine is transferred to 2-oxoglutarate to form glutamate and phosphohydroxypyruvate.

Transamination: The reaction begins with PLP forming a Schiff base with a lysine residue in the active site, facilitating amino group transfer.
Substrate specificity: PSAT1 shows high specificity for 3-phosphoserine, with a Km value of approximately 0.8 mM under physiological conditions.
Cofactor dependence:Pyridoxal 5'-phosphate (vitamin B6 derivative) is essential; deficiency impairs enzyme function and serine synthesis.
Reversibility: The reaction is reversible, allowing metabolic flexibility depending on cellular demand for serine or glutamate.
Regulation: Activity is modulated by feedback inhibition from serine and transcriptional control via the ATF4 pathway during stress responses.
Protein structure: Human PSAT1 forms a homodimer with each subunit containing ~370 amino acids and a molecular mass of ~42 kDa.

Comparison at a Glance

Comparing PSAT1 to other enzymes in serine metabolism highlights its unique role and regulatory mechanisms.

Enzyme	Gene	Reaction Step	Km (mM)	Tissue Expression
3-Phosphoglycerate dehydrogenase	PHGDH	First step	1.2	Liver, brain
3-Phosphoserine aminotransferase	PSAT1	Second step	0.8	Liver, brain, pancreas
Phosphoserine phosphatase	PSPH	Third step	0.5	Ubiquitous
Serine hydroxymethyltransferase	SHMT1/2	Serine utilization	0.3	Cytosol, mitochondria
Alanine aminotransferase	ALT1	Non-specific	5.0	Liver, muscle

The table illustrates that PSAT1 operates with relatively high substrate affinity compared to upstream and downstream enzymes. Its tissue-specific expression underscores its importance in organs with high metabolic demand. Unlike more generalized aminotransferases like ALT1, PSAT1 is specialized for serine biosynthesis, making it a key regulatory node.

Why It Matters

Understanding 3-phosphoserine aminotransferase is vital for diagnosing and treating rare metabolic disorders and neurodegenerative conditions linked to serine deficiency.

Clinical significance: Biallelic mutations in PSAT1 cause neurodevelopmental delay, microcephaly, and seizures due to impaired brain serine levels.
Therapeutic use: Oral L-serine supplementation can partially reverse symptoms in patients with PSAT1 deficiency.
Cancer metabolism: Some tumors upregulate PSAT1 to support rapid cell proliferation and nucleotide synthesis.
Neuroprotection: Serine derived from PSAT1 activity is a precursor to D-serine, a co-agonist of NMDA receptors involved in learning and memory.
Biomarker potential: Elevated PSAT1 expression in serum or tissues may indicate metabolic stress or early-stage cancer.
Drug development: Inhibitors targeting PSAT1 are being explored for anti-cancer therapies in tumors dependent on serine biosynthesis.

As research advances, PSAT1 continues to emerge as a pivotal enzyme at the intersection of metabolism, neurology, and oncology, offering new avenues for diagnosis and treatment.